CalciMedica, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
CalciMedica, Inc. (CALC) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $11.50 million as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2023-03-09
- 2022-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $11.50M.
- 2022-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $13.50M.
- 2022-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $13.90M.
- 2022-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $15.50M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2022-12-31 | $11.50M 10-K · filed 2023-03-09 |
| 2022-09-30 | $13.50M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $13.90M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $15.50M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $15.40M 10-K · filed 2022-03-11 |
| 2021-09-30 | $16.90M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $19.20M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $13.40M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $15.00M 10-K · filed 2021-03-05 |
| 2020-09-30 | $7.60M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |